Company Announces $10 Million Towards The Development of an Experimental Multiple Sclerosis Drug
Pexels / Pixabay

Company Announces $10 Million Towards The Development of an Experimental Multiple Sclerosis Drug

According to a story from pm360online.com, the biopharmaceutical company Principia Biopharma recently announced that they had achieved $10 million in milestones that are related to the development of its experimental…

Continue Reading Company Announces $10 Million Towards The Development of an Experimental Multiple Sclerosis Drug
Research Reveals Relationship Between Multiple Sclerosis and Digestive System Flora
qimono / Pixabay

Research Reveals Relationship Between Multiple Sclerosis and Digestive System Flora

According to a story from EurekAlert!, a recent study from the University of Zurich has illuminated the connection between the gastrointestinal flora and multiple sclerosis. The discovery illuminates the potential…

Continue Reading Research Reveals Relationship Between Multiple Sclerosis and Digestive System Flora
A Biomarker, an App, and Real-World Data: How Biogen is Trying to Improve Treatment for Patients With Multiple Sclerosis
Bru-nO / Pixabay

A Biomarker, an App, and Real-World Data: How Biogen is Trying to Improve Treatment for Patients With Multiple Sclerosis

As part of their work to support the treatment of patients with multiple sclerosis, Biogen has been investigating a potential new biomarker for the disease called serum neurofilament light (sNfL),…

Continue Reading A Biomarker, an App, and Real-World Data: How Biogen is Trying to Improve Treatment for Patients With Multiple Sclerosis
This Immunotherapy Could be a Useful Treatment for Amyotrophic Lateral Sclerosis
Bru-nO / Pixabay

This Immunotherapy Could be a Useful Treatment for Amyotrophic Lateral Sclerosis

According to a story from the Houston Chronicle, researchers are hoping that an immunotherapy treatment that was originally funded by an Ice Bucket Challenge grant could be a viable option…

Continue Reading This Immunotherapy Could be a Useful Treatment for Amyotrophic Lateral Sclerosis

A Type of Brain Cell Researchers Named ‘ieAstrocytes’ have Been Implicated in Brain Inflammation

A recently published study has highlighted the role of a sub-group of astrocytes (a type of brain cell) in brain inflammation, which can be a feature of multiple serious diseases,…

Continue Reading A Type of Brain Cell Researchers Named ‘ieAstrocytes’ have Been Implicated in Brain Inflammation
Researchers are Looking for People Diagnosed with Multiple Sclerosis to Take Part in a Phone App Study
JESHOOTScom / Pixabay

Researchers are Looking for People Diagnosed with Multiple Sclerosis to Take Part in a Phone App Study

Researchers are looking for participants to take part in a study investigating whether a mobile app could benefit patients with multiple sclerosis. For more information about this study and how…

Continue Reading Researchers are Looking for People Diagnosed with Multiple Sclerosis to Take Part in a Phone App Study
Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests
qimono / Pixabay

Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests

According to a story from Multiple Sclerosis News Today, a recent case report suggests that switching from the immunotherapy drug Gilenya to another immunotherapy called Lemtrada could cause a severe…

Continue Reading Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests
So Why DOES Canada have Scarcer Access to Rare Disease Therapies?
FrankWinkler / Pixabay

So Why DOES Canada have Scarcer Access to Rare Disease Therapies?

According to a story from CheckOrphan, Durhane Wong-Rieger, the CEO of the Canadian Organization for Rare Disorders, says that the Canadian health system has been letting down the roughly three…

Continue Reading So Why DOES Canada have Scarcer Access to Rare Disease Therapies?